Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study
Central European Journal of Urology · 2026 · 79 (2) · 133-139
DOI: 10.5173/ceju.2025.0315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central European Journal of Urology, 2026. Verfasst von Shunsuke Watanabe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Urology, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
- Department of Urology, JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu, Japan.
- Department of Urology, Fujieda Municipal General Hospital, Fujieda, Japan.
- Department of Urology, Iwata City Hospital, Iwata, Japan.
- Department of Urology, Chutoen General Medical Center, Kakegawa, Japan.
Zitieren
APA
Watanabe, S., Kitagawa, Y., Uchiyama, A., Oishi, Y., Tanaka, H., Ishikawa, G., Watanabe, S., Suzuki, E., Watanabe, K., Matsushita, Y., Watanabe, H., Tamura, K., Matsumoto, R., Motoyama, D., Nagata, M., & Inamoto, T. (2026). Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study. Central European Journal of Urology, 79(2), 133-139. https://doi.org/10.5173/ceju.2025.0315
Vancouver
Watanabe S, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Ishikawa G, et al. Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study. Central European Journal of Urology. 2026;79(2):133-139. doi:10.5173/ceju.2025.0315
BibTeX
@article{Watanabe2026,
author = {Watanabe, Shunsuke and Kitagawa, Yuichi and Uchiyama, Asuka and Oishi, Yuya and Tanaka, Hiroki and Ishikawa, Gaku and Watanabe, Shinya and Suzuki, Eito and Watanabe, Kyohei and Matsushita, Yuto and Watanabe, Hiromitsu and Tamura, Keita and Matsumoto, Rikiya and Motoyama, Daisuke and Nagata, Masao and Inamoto, Teruo},
title = {Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study},
journal = {Central European Journal of Urology},
year = {2026},
volume = {79},
number = {2},
pages = {133--139},
doi = {10.5173/ceju.2025.0315}
}
EUVIMED